查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1715770

PCR 技术市场（按产品类型、技术、应用和最终用户划分）—2025 年至 2030 年全球预测

PCR Technologies Market by Product Type, Technique, Application, End-user - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

PCR技术市场预计2023年价值38.7亿美元，2024年成长至41.5亿美元，复合年增长率为7.63%，到2030年达到64.8亿美元。

主要市场统计数据
基准年2023年 38.7亿美元
预计2024年 41.5亿美元
预测年份 2030 64.8亿美元
复合年增长率（%） 7.63%

PCR 技术已发展成为现代分子生物学的基石，彻底改变了研究人员和临床医生进行基因分析的方式。这份综合报告提供了当前市场状况的整体视图，捕捉了影响产业的关键驱动因素、新兴趋势和挑战。这一领域的特点是先进仪器、微型试剂和强大的计算工具的强大创新，所有这些都有助于提高各种应用的灵敏度、精度和吞吐量。

PCR技术的演进不仅是实验室不断改进的故事，也是策略市场转型和采用新方法拓宽应用范围的故事。在这个横跨多个领域的行业中，从医疗保健领域的诊断应用到学术界和政府的研究倡议，准确了解当前动态的重要性怎么强调也不为过。随着 PCR 新变体的出现和传统方法的增强，该领域继续满足对快速、可靠和可扩展的基因检测解决方案日益增长的需求。

本介绍概述了技术进步和市场力量之间的相互作用。透过深入的分析，相关人员可以了解该行业的深度和广度，并做好准备，利用机会并应对未来几年的潜在挑战。这些内容为决策者、行业专家和投资者在这个不断变化的领域寻求可行的见解和策略方向奠定了基础。

改变PCR技术市场

近年来，PCR技术市场发生了重大变化。技术创新一直是主要的催化剂，推动新平台的发展，突破了敏感性和特异性的界限。聚合酵素连锁反应热迴圈仪设计、整合机器人和自动化系统的改进重新定义了全球实验室的业务效率。增强的软体功能和先进的数据分析使研究人员能够比以往更快地处理和解释大量数据。

同时，数位解决方案日益重要，正在再形成市场。例如，数位 PCR 方法的引入提供了出色的定量准确性，这在检测复杂样本中的低丰度遗传物质时尤其有益。这种数位化大大提高了可靠性和可重复性，提供了可靠、准确的结果。这些技术飞跃凸显了朝向更整合、高通量系统的趋势，该系统能够满足多样化的研究和诊断需求。

另一个变革是 PCR 技术适应专门的应用。越来越多的实验室开始采用针对其独特挑战量身定制的技术，例如可以同时检测多个目标的多重 PCR 和对于病毒诊断和基因表现研究中的 RNA 分析至关重要的逆转录 PCR。在该领域，方法创新和不断变化的用户需求的双重影响正在刺激整个价值链上产品系列的快速扩张和多样化。

此外，市场动态在很大程度上受到研究机构之间的合作努力和技术发展的影响。伙伴关係和策略联盟变得越来越普遍，共用知识专长和资源以加速产品进步。加上全球对个人化医疗和精准诊断的日益关注，这些转变正在持久地改变竞争格局，为更灵活和更具适应性的市场结构奠定基础。

深入了解 PCR 技术的关键细分领域

市场区隔透过概述四个主要观点提供了 PCR 技术的详细视图，这些观点不仅可以区分产品供应，还可以作为市场分析的策略指南。依产品类型细分，探索仪器、试剂和消耗品以及软体和服务等产业。设备经过彻底检查，并分解为关键的子类别，例如维持讯号保真度的萤光检测器、确保精确温度控制的加热块、为样品最佳化而设计的 PCR 管和板、透过自动化确保可重复性的机器人液体处理器，以及对重复实验至关重要的聚合酵素连锁反应热迴圈仪。类似地，试剂和消耗品类别包括用于稳定反应的缓衝液、用于实现检测的染料、用于启动扩增过程的引子以及用于确保目标特异性的探针。软体和服务也经过了严格的分析，重点是将实验数据转化为可操作见解的数据分析软体，以及简化研究方法的引子设计工具。

按技术分类时，会出现各种各样的 PCR 方法，每种方法都旨在满足特定的分析要求。虽然传统 PCR 仍然是基石技术，但数位 PCR 提供了检测低拷贝目标所需的准确定量解决方案。热启动 PCR 透过减少不必要的扩增来提高特异性，而甲基化特异性PCR 则是专门为表观遗传学研究而设计的。多重 PCR 透过实现同时标记检测而获得了关注，而即时PCR正在建立即时监控能力以提供动态诊断见解。逆转录-PCR 是 RNA 研究必不可少的技术，现已进一步细分为一步和两步 RT-PCR 技术，展现了基因表现分析中效率和灵活性之间的复杂平衡。

根据应用进行细分，突出显示了 PCR 技术如何渗透到各个领域。诊断应用仍然是最受探索的领域，对医疗保健和疾病管理有直接影响。环境应用也越来越受到人们的兴趣，特别是在公共卫生监测和保护方面。基因表现分析、基因序列测定和基因型鉴定是研究环境中的核心领域，需要高度的准确性和可重复性。同时，核酸检测和合成体现了PCR技术的多功能性，并结合标准验证和检验活动，确保实验设计的准确性和一致性。

从最终用户的观点来看，透过将市场分为学术和政府机构、应用产业、医疗保健产业、医院和诊断中心以及製药和生物技术公司，细分提供了深刻的分析。每个使用者类别都表现出独特的动态和客製化要求，反映了推动研究和商业性创新的广泛使用频谱和多样化的市场需求。这种细分洞察使行业专业人士和决策者能够应对复杂的商业环境、发现策略性投资机会并更好地使产品供应满足特定客户的需求。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 对 PCR 技术中准确、快速诊断测试的需求不断增加
      • 政府推动 PCR 技术进步和加强实验室基础设施的倡议
      • 慢性病和感染疾病激增导致全球对 PCR 诊断的需求
    • 限制因素
      • 限制PCR有效性和效率的技术问题
    • 机会
      • 对高效能多靶点检测的需求日益增长
      • PCR技术在环境监测与评估的新应用.
    • 任务
      • 与新兴诊断技术的竞争
  • 市场区隔分析
    • 产品类型：PCR仪器技术进步
    • 技术：传统 PCR 和即时PCR因其完善的方法而在市场上占有重要地位。
    • 应用：PCR技术在诊断应用的重要用途
    • 最终用户：PCR 技术在医疗保健产业需求旺盛，以满足大规模检测需求
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

第六章 PCR技术市场（依产品类型）

  • 装置
    • 萤光检测器
    • 加热块
    • PCR 管和板
    • 机器人液体处理器
    • 聚合酵素连锁反应热迴圈仪
  • 试剂和耗材
    • 缓衝
    • 染料
    • 底漆
    • 探测
  • 软体和服务
    • 数据分析软体
    • 引子设计工具

第七章 PCR 技术市场：依技术分类

  • 常规PCR
  • 数位PCR
    • 液滴式数位PCR
    • 基于奈米板的数位PCR
  • 热启动PCR
  • 甲基化特异性PCR
  • 多重PCR
  • 即时PCR
  • 逆转录PCR
    • 一步法RT-PCR
    • 两步RT-PCR

第 8 章 PCR 技术市场：按应用

  • 诊断应用
  • 环境应用
  • 基因表现分析
  • 基因序列分析
  • 基因分型
  • 核酸检测
  • 核酸合成
  • 标准检验/检验

第九章 PCR技术市场（按最终用户）

  • 学术和政府机构
  • 应用产业
  • 医疗保健产业
  • 医院和诊断中心
  • 製药生物技术公司

第 10 章美洲 PCR 技术市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第11章亚太PCR技术市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲的PCR技术市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023年市场占有率分析
  • 2023年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Analytik Jena GmbH+Co. KG
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Bioneer Corporation
  • Danaher Corporation
  • Enzo Biochem Inc.
  • Eppendorf SE
  • F. Hoffmann-La Roche Ltd.
  • HiMedia Laboratories Pvt. Ltd
  • Illumina, Inc.
  • JN Medsys Pte. Ltd.
  • Merck KGaA
  • Norgen Biotek Corp.
  • Perkin Elmer, Inc.
  • Promega Corporation
  • Qiagen NV
  • QuantuMDx Group Ltd
  • Sansure Biotech, Inc.
  • Siemens Helathineers AG
  • Standard BioTools Inc.
  • Takara Bio, Inc.
  • Thermo Fisher Scientific, Inc.
  • TransGen Biotech Co., LTD.
Product Code: MRR-FD3F12D53D2D

The PCR Technologies Market was valued at USD 3.87 billion in 2023 and is projected to grow to USD 4.15 billion in 2024, with a CAGR of 7.63%, reaching USD 6.48 billion by 2030.

KEY MARKET STATISTICS
Base Year [2023] USD 3.87 billion
Estimated Year [2024] USD 4.15 billion
Forecast Year [2030] USD 6.48 billion
CAGR (%) 7.63%

PCR technologies have evolved to become a cornerstone of modern molecular biology, revolutionizing the way researchers and clinicians approach genetic analysis. This comprehensive report provides a holistic view of the current state of the market, capturing key drivers, emerging trends, and challenges that are shaping the industry. The landscape is characterized by robust innovation in advanced instrumentation, differential reagents, and powerful computational tools, all of which contribute to increasing sensitivity, precision, and throughput in various applications.

The evolution of PCR technology is not just a story of progressive improvements in the laboratory, but also a tale of strategic market transformations and the adaptation of new methodologies that broaden application scopes. With an industry that now extends across multiple sectors - from diagnostic applications in healthcare to research initiatives in academia and governments - the importance of accurately understanding the present dynamics cannot be overstated. As new variants of PCR emerge and traditional methods are enhanced, the sector continues to meet escalating demands for rapid, reliable, and scalable genetic testing solutions.

This introduction sets the stage by outlining the interplay between technological advancement and market forces. Through insightful analysis, stakeholders can appreciate the depth and breadth of the sector, positioning themselves to leverage opportunities and address potential challenges in the coming years. The content here establishes a foundational comprehension required by decision-makers, industry experts, and investors looking for actionable insights and strategic direction in this ever-changing field.

Transformative Shifts in the PCR Technological Landscape

Recent years have witnessed significant transformative shifts that underline the evolution of the PCR technologies market. Technological innovation has been a primary catalyst, driving the development of new platforms that push the boundaries of sensitivity and specificity. Improvements in thermal cycler design, integrated robotics, and automation systems have redefined operational efficiency in laboratories globally. Enhanced software capabilities and advanced data analytics further empower researchers to process and interpret large volumes of data with unprecedented speed.

Concurrently, the market has been reshaped by the rising importance of digital solutions. The incorporation of digital PCR methods, for instance, provides exceptional quantification precision that is particularly beneficial when detecting low abundance genetic material in complex samples. This digital adaptation has led to significant improvements in reliability and reproducibility, ensuring that results are both robust and accurate. Such technological leaps underscore a movement towards more integrated, high-throughput systems that are capable of handling diverse research and diagnostic demands.

Another transformative shift lies in the adaptation of PCR techniques to meet specialized applications. Laboratories are increasingly embracing techniques tailored for unique challenges, such as multiplex PCR, which enables simultaneous detection of multiple targets, and reverse transcription PCR, which is pivotal for RNA analysis in viral diagnostics and gene expression studies. The sector is actively witnessing the dual impact of methodology innovations and evolving user requirements, a combination that is fueling rapid expansion and diversification of the product portfolio across the value chain.

Furthermore, market dynamics have been substantially affected by collaborative efforts between research institutions and technology developers. As partnerships and strategic alliances become more frequent, the distribution of intellectual expertise and resource pooling is contributing to accelerated product advancements. Coupled with the intensification of the global focus on personalized medicine and precision diagnostics, these shifts are sustainably altering the competitive landscape and setting the stage for a more versatile and adaptive market structure.

Key Segmentation Insights in PCR Technologies

The market's segmentation offers a detailed view of PCR technologies by outlining four key perspectives that not only differentiate the offerings but also act as strategic guides for market analysis. The segmentation based on product type examines the industry across instruments, reagents and consumables, and software and services. Instruments have undergone meticulous study, breaking down into critical sub-categories such as fluorescence detectors that maintain signal accuracy, heat blocks that ensure precise temperature control, PCR tubes and plates designed for sample optimization, robotic liquid handlers that guarantee reproducibility through automation, and thermal cyclers which lie at the core of experimental replication. Similarly, the reagents and consumables category encompasses buffer solutions that stabilize reactions, dyes that enable detection, primers that initiate the amplification process, and probes that ensure target specificity. Software and services also receive rigorous analysis with a focus on data analysis software that translates experimental data into actionable insights and primer design tools that streamline research processes.

Segmentation by technique reveals an extensive array of PCR methodologies, each designed to address specific analytical requirements. Conventional PCR remains a foundational method, while digital PCR offers precise quantification solutions that are critical for detecting low-copy targets. Hot-start PCR enhances specificity by reducing unwanted amplifications, and methylation-specific PCR is uniquely tailored for epigenetic studies. Multiplex PCR has gained traction by enabling simultaneous marker detection, and real-time PCR builds on real-time monitoring capabilities to provide dynamic diagnostic insights. Reverse transcription PCR, indispensable in RNA studies, is further dissected to include one-step and two-step RT-PCR methodologies, illustrating the intricate balance between efficiency and flexibility in gene expression analysis.

The segmentation based on application underscores how PCR technologies have penetrated diverse fields. Diagnostic applications remain the most explored segment with direct implications in healthcare and disease management. Environmental applications are also of increasing interest, particularly in monitoring and protecting public health. Gene expression analysis, genetic sequencing, and genotyping represent core areas within research settings that demand high precision and replicability. Meanwhile, nucleic acid detection and synthesis, along with standard validation and verification activities, exemplify the versatile nature of PCR technology in ensuring accurate and consistent experimental designs.

When benchmarked against end-user perspectives, the segmentation provides insightful analysis by categorizing the market into academia and government organizations, applied industries, the healthcare industry, hospitals and diagnostic centers, and pharma-biotech companies. Each of these user categories presents unique dynamics and tailored requirements, reflecting the broad usage spectrum and the varied market demands that drive research and commercial innovations. These segmentation insights collectively enable industry professionals and decision-makers to navigate the complexities of the business environment, identify opportunities for strategic investment, and enhance the alignment of product offerings with specific customer needs.

Based on Product Type, market is studied across Instruments, Reagents & Consumables, and Software & Services. The Instruments is further studied across Fluorescence Detectors, Heat Blocks, PCR Tubes & Plates, Robotic Liquid Handlers, and Thermal Cyclers. The Reagents & Consumables is further studied across Buffer Solution, Dyes, Primers, and Probes. The Software & Services is further studied across Data Analysis Software and Primer Design Tools.

Based on Technique, market is studied across Conventional PCR, Digital PCR, Hot-Start PCR, Methylation-specific PCR, Multiplex PCR, Real-Time PCR, and Reverse Transcription PCR. The Digital PCR is further studied across Droplet Digital PCR and Nanoplate-based Digital PCR. The Reverse Transcription PCR is further studied across One-step RT-PCR and Two-step RT-PCR.

Based on Application, market is studied across Diagnostic Applications, Environmental Applications, Gene Expression Analysis, Genetic Sequencing, Genotyping, Nucleic Acid Detection, Nucleic Acid Synthesis, and Standard Validation/Verification.

Based on End-user, market is studied across Academia & Government Organizations, Applied Industries, Healthcare Industry, Hospitals & Diagnostic Centers, and Pharma-Biotech Companies.

Key Regional Insights in the PCR Technologies Market

A comprehensive regional analysis reveals distinct growth patterns and competitive nuances in three major global regions. In the Americas, mature market infrastructures and robust funding mechanisms have laid a strong foundation for continuous innovation and expansion. The market dynamics in this region are bolstered by state-of-the-art research facilities and a well-established healthcare system, making it an epicenter of technological advancement and clinical applications.

Across Europe, the Middle East, and Africa, research and regulatory environments are evolving, catalyzing growth even in traditionally challenging markets. The regulatory frameworks and governmental initiatives in these regions are increasingly geared toward fostering innovation, which supports the adoption of advanced PCR methodologies. Collaborative research projects and cross-industry partnerships further accelerate the diffusion of knowledge and technology transfer, enabling a more integrated approach to market expansion in this diverse mix of developed and emerging economies.

The Asia-Pacific region presents a dynamic and rapidly evolving landscape, marked by significant investments in research infrastructure and emerging public-private partnerships. Rapid industrialization, combined with government initiatives focusing on healthcare development and biotechnological innovation, has fueled robust market growth. Increased awareness and adoption of advanced diagnostic and research methodologies in this region underscore its potential as not only an emerging market but also a future global leader in PCR technology development and application.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Shaping the PCR Technologies Industry

The PCR technologies market is defined by the presence of influential companies that drive competitive dynamics through relentless innovation and a commitment to quality. Industry giants such as Abbott Laboratories and Agilent Technologies, Inc. have traditionally set high standards with their comprehensive product portfolios and cutting-edge research facilities. Analytik Jena GmbH+Co. KG and Becton, Dickinson and Company continue to redefine technological boundaries by integrating automation and digitization into their instruments. Meanwhile, Bio-Rad Laboratories, Inc. and bioMerieux SA consistently push the envelope in ensuring analytical precision across diagnostic applications.

Bioneer Corporation, Danaher Corporation, and Enzo Biochem Inc. further enhance the competitive landscape by delivering specialized solutions that address unique market challenges, thereby broadening the scope of traditional PCR applications. Eppendorf SE and F. Hoffmann-La Roche Ltd. have established themselves as key innovators, offering robust instruments that emphasize efficiency and reliability in high-demand settings. High-performing entities such as HiMedia Laboratories Pvt. Ltd. and Illumina, Inc. are actively expanding their market reach through a blend of research-driven innovation and strategic market penetration.

JN Medsys Pte. Ltd. and Merck KGaA are noted for their commitment to research excellence and technological adaptability. Their ongoing investments in research have fostered the development of high-precision techniques that respond to ever-changing market needs. Companies like Norgen Biotek Corp. and Perkin Elmer, Inc. further solidify industry standards by offering comprehensive solutions across multiple PCR platforms. Promega Corporation and Qiagen N.V. are also at the forefront, delivering breakthrough technologies that constantly redefine user expectations by ensuring data integrity and operational efficiency.

The competitive landscape is additionally supported by the contributions of emerging players such as QuantuMDx Group Ltd and Sansure Biotech, Inc., who continuously identify niche segments to exploit and innovate within. Leading organizations including Siemens Healthineers AG, Standard BioTools Inc., Takara Bio, Inc., Thermo Fisher Scientific, Inc., and TransGen Biotech Co., LTD also play instrumental roles in steering market direction through robust research programs and unparalleled service quality. Collectively, these companies offer a mosaic of skills, resources, and market insights that foster an environment conducive to both incremental and breakthrough innovations in PCR technologies.

The report delves into recent significant developments in the PCR Technologies Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Analytik Jena GmbH+Co. KG, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux SA, Bioneer Corporation, Danaher Corporation, Enzo Biochem Inc., Eppendorf SE, F. Hoffmann-La Roche Ltd., HiMedia Laboratories Pvt. Ltd, Illumina, Inc., JN Medsys Pte. Ltd., Merck KGaA, Norgen Biotek Corp., Perkin Elmer, Inc., Promega Corporation, Qiagen N.V., QuantuMDx Group Ltd, Sansure Biotech, Inc., Siemens Helathineers AG, Standard BioTools Inc., Takara Bio, Inc., Thermo Fisher Scientific, Inc., and TransGen Biotech Co., LTD.. Actionable Recommendations for Industry Leaders in PCR Technologies

In light of robust industry dynamics and ongoing technological advancements, the following actionable recommendations offer strategic guidance for leaders in the PCR market. Stakeholders are encouraged to invest systematically in next-generation sequencing and digital transformation initiatives to stay ahead in a highly competitive market. In particular, firms should explore emerging areas such as droplet digital PCR and nanoplate-based digital assays to secure competitive advantages in sensitivity and precision.

Leaders are advised to focus on deepening their segmentation strategies by tailoring products and services to specific customer requirements. By refining product differentiation across the instruments, reagents and consumables, and software and services segments, companies can better capture market share. Continuous improvements in automation and integration of sophisticated data analytics are pivotal, as these enhancements not only lead to operational efficiency but also improve the overall user experience.

It is also recommended that firms invest in comprehensive research and development programs that prioritize cross-functional collaborations with academic research centers, healthcare institutions, and industry consortia. Such partnerships can yield innovative solutions that address niche market demands and streamline regulatory pathways. Furthermore, companies should consider expanding their geographical outreach in mature markets such as the Americas as well as strategically emerging regions like Asia-Pacific, where research investment and healthcare reforms are actively reshaping market dynamics.

Another crucial recommendation is to bolster digital infrastructure in order to harness the full potential of real-time data analysis and predictive modeling. Developing robust digital platforms not only enhances operational insights but also positions companies to rapidly respond to changes in market dynamics. Emphasizing data security and regulatory compliance in digital transformation projects will ensure that these technological innovations are sustainable in the long term.

Finally, aligning strategic initiatives with future market trends and regulatory updates will be essential. Industry leaders should adopt proactive measures to monitor global standards and technological benchmarks, thereby ensuring that their innovation strategies remain aligned with contemporary market demands. This approach of continuous innovation combined with agile, data-driven decision-making will help companies to maintain a competitive edge and evolve in step with the dynamic PCR technologies landscape.

Conclusion of the Executive Summary

A holistic analysis of the PCR technologies market reveals a sophisticated landscape marked by rapid technological advancements and evolving consumer expectations. The study has outlined transformative shifts that underscore the interplay between cutting-edge innovation and strategic market evolution. Through detailed segmentation, the report has not only captured the diverse product range and technique applications but also clarified the varied end-user demands that drive product development and enhancements.

The convergence of progressive instrumentation, innovative reagents, and advanced software solutions creates an environment where precise diagnostics and research capabilities flourish. Regional insights further highlight a global trend wherein mature markets blend seamlessly with emerging sectors to create a robust and dynamic geographical spread. Additionally, the competitive landscape, as demonstrated by the significant roles played by industry-leading companies, underpins the potential for continued breakthroughs and market expansion.

In essence, the report serves as an invaluable resource for decision-makers seeking to harness the full potential of PCR technologies. The combination of detailed market segmentation, regional analysis, and strategic recommendations creates an actionable framework that can guide future investments and drive sustained growth. As industry leaders navigate these developments, the emphasis on innovation, tailored solutions, and cross-sector collaborations will be paramount.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising demand for precise and rapid diagnostic testing in PCR technologies
      • 5.1.1.2. Government initiatives fueling advancements in PCR technology and enhancing laboratory infrastructures
      • 5.1.1.3. Global demand for PCR diagnostics amid the surge in chronic and infectious diseases
    • 5.1.2. Restraints
      • 5.1.2.1. Technological issues limiting the effectiveness and efficiency of PCR methods
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing demand for efficient multi-target assays
      • 5.1.3.2. Emerging applications of PCR technologies in environmental monitoring and assessment
    • 5.1.4. Challenges
      • 5.1.4.1. Competition from emerging diagonstic technologies
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Type : Technological advancements in PCR instruments
    • 5.2.2. Technique: Significant market presence of conventional PCR and real-time PCR due to their established methodologies
    • 5.2.3. Application : Significant usage of PCR technologies in diagnostic applications
    • 5.2.4. End-user : High demand for PCR technologies in healthcare industry to meet large-scale testing needs
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. PCR Technologies Market, by Product Type

  • 6.1. Introduction
  • 6.2. Instruments
    • 6.2.1. Fluorescence Detectors
    • 6.2.2. Heat Blocks
    • 6.2.3. PCR Tubes & Plates
    • 6.2.4. Robotic Liquid Handlers
    • 6.2.5. Thermal Cyclers
  • 6.3. Reagents & Consumables
    • 6.3.1. Buffer Solution
    • 6.3.2. Dyes
    • 6.3.3. Primers
    • 6.3.4. Probes
  • 6.4. Software & Services
    • 6.4.1. Data Analysis Software
    • 6.4.2. Primer Design Tools

7. PCR Technologies Market, by Technique

  • 7.1. Introduction
  • 7.2. Conventional PCR
  • 7.3. Digital PCR
    • 7.3.1. Droplet Digital PCR
    • 7.3.2. Nanoplate-based Digital PCR
  • 7.4. Hot-Start PCR
  • 7.5. Methylation-specific PCR
  • 7.6. Multiplex PCR
  • 7.7. Real-Time PCR
  • 7.8. Reverse Transcription PCR
    • 7.8.1. One-step RT-PCR
    • 7.8.2. Two-step RT-PCR

8. PCR Technologies Market, by Application

  • 8.1. Introduction
  • 8.2. Diagnostic Applications
  • 8.3. Environmental Applications
  • 8.4. Gene Expression Analysis
  • 8.5. Genetic Sequencing
  • 8.6. Genotyping
  • 8.7. Nucleic Acid Detection
  • 8.8. Nucleic Acid Synthesis
  • 8.9. Standard Validation/Verification

9. PCR Technologies Market, by End-user

  • 9.1. Introduction
  • 9.2. Academia & Government Organizations
  • 9.3. Applied Industries
  • 9.4. Healthcare Industry
  • 9.5. Hospitals & Diagnostic Centers
  • 9.6. Pharma-Biotech Companies

10. Americas PCR Technologies Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific PCR Technologies Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa PCR Technologies Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. QIAGEN expands its digital PCR footprint with QIAcuityDx, enhancing clinical diagnostics in oncology
    • 13.3.2. Molecular Designs' strategic acquisition of Lamda Biotech boosts product offerings in PCR and genomics
    • 13.3.3. QIAGEN expands digital PCR capabilities with over 100 new assays enhancing the GeneGlobe platform offerings
    • 13.3.4. Takara Bio launches SmartChip ND System designed for antimicrobial resistance monitoring
    • 13.3.5. Siemens Healthcare introduces indigenous RT-PCR kit for swift detection of Monkeypox in India
    • 13.3.6. Virax Biolabs has revealed a distribution agreement for Mpox RT-PCR kits across Europe and the Middle East
    • 13.3.7. Agilent's strategic acquisition of Sigsense, creator of AI-enabled lab operations technology
    • 13.3.8. Bio-Rad highlights its progress utilizing droplet digital PCR in the biopharmaceutical and translational research fields
    • 13.3.9. Stilla Technologies expands its digital PCR lineup with breakthrough Nio configurations, earning industry acclaim
    • 13.3.10. Bio-Rad collaborates with Oncocyte to advance transplant monitoring using innovative droplet digital PCR
    • 13.3.11. Analytik Jena showcase three new products at analytica 2024
    • 13.3.12. Strategic partnership between Standard BioTools and NGD for cost-effective pathogen sequencing
    • 13.3.13. Stilla Technologies advances digital PCR platform with USD 26.5M financing and strategic expansions
  • 13.4. Strategy Analysis & Recommendation
    • 13.4.1. Thermo Fisher Scientific, Inc.
    • 13.4.2. F. Hoffmann-La Roche Ltd.
    • 13.4.3. Abbott Laboratories
    • 13.4.4. Bio-Rad Laboratories, Inc

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Agilent Technologies, Inc.
  • 3. Analytik Jena GmbH+Co. KG
  • 4. Becton, Dickinson and Company
  • 5. Bio-Rad Laboratories, Inc.
  • 6. bioMerieux SA
  • 7. Bioneer Corporation
  • 8. Danaher Corporation
  • 9. Enzo Biochem Inc.
  • 10. Eppendorf SE
  • 11. F. Hoffmann-La Roche Ltd.
  • 12. HiMedia Laboratories Pvt. Ltd
  • 13. Illumina, Inc.
  • 14. JN Medsys Pte. Ltd.
  • 15. Merck KGaA
  • 16. Norgen Biotek Corp.
  • 17. Perkin Elmer, Inc.
  • 18. Promega Corporation
  • 19. Qiagen N.V.
  • 20. QuantuMDx Group Ltd
  • 21. Sansure Biotech, Inc.
  • 22. Siemens Helathineers AG
  • 23. Standard BioTools Inc.
  • 24. Takara Bio, Inc.
  • 25. Thermo Fisher Scientific, Inc.
  • 26. TransGen Biotech Co., LTD.

LIST OF FIGURES

  • FIGURE 1. PCR TECHNOLOGIES MARKET MULTI-CURRENCY
  • FIGURE 2. PCR TECHNOLOGIES MARKET MULTI-LANGUAGE
  • FIGURE 3. PCR TECHNOLOGIES MARKET RESEARCH PROCESS
  • FIGURE 4. PCR TECHNOLOGIES MARKET SIZE, 2023 VS 2030
  • FIGURE 5. GLOBAL PCR TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS PCR TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS PCR TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES PCR TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES PCR TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC PCR TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC PCR TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PCR TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA PCR TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. PCR TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. PCR TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PCR TECHNOLOGIES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PCR TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PCR TECHNOLOGIES MARKET DYNAMICS
  • TABLE 7. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY FLUORESCENCE DETECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY HEAT BLOCKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY PCR TUBES & PLATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY ROBOTIC LIQUID HANDLERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY THERMAL CYCLERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY BUFFER SOLUTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY DYES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY PRIMERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY PROBES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY PRIMER DESIGN TOOLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY CONVENTIONAL PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY DROPLET DIGITAL PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY NANOPLATE-BASED DIGITAL PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY HOT-START PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY METHYLATION-SPECIFIC PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY MULTIPLEX PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY REVERSE TRANSCRIPTION PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY ONE-STEP RT-PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY TWO-STEP RT-PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY REVERSE TRANSCRIPTION PCR, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY ENVIRONMENTAL APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY GENE EXPRESSION ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY GENETIC SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY GENOTYPING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY NUCLEIC ACID DETECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY NUCLEIC ACID SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY STANDARD VALIDATION/VERIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY ACADEMIA & GOVERNMENT ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY APPLIED INDUSTRIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY HEALTHCARE INDUSTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY PHARMA-BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS PCR TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS PCR TECHNOLOGIES MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS PCR TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 59. AMERICAS PCR TECHNOLOGIES MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 60. AMERICAS PCR TECHNOLOGIES MARKET SIZE, BY REVERSE TRANSCRIPTION PCR, 2018-2030 (USD MILLION)
  • TABLE 61. AMERICAS PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. AMERICAS PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. AMERICAS PCR TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. ARGENTINA PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. ARGENTINA PCR TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 66. ARGENTINA PCR TECHNOLOGIES MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 67. ARGENTINA PCR TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 68. ARGENTINA PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 69. ARGENTINA PCR TECHNOLOGIES MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 70. ARGENTINA PCR TECHNOLOGIES MARKET SIZE, BY REVERSE TRANSCRIPTION PCR, 2018-2030 (USD MILLION)
  • TABLE 71. ARGENTINA PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. ARGENTINA PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. BRAZIL PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. BRAZIL PCR TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 75. BRAZIL PCR TECHNOLOGIES MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 76. BRAZIL PCR TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 77. BRAZIL PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 78. BRAZIL PCR TECHNOLOGIES MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 79. BRAZIL PCR TECHNOLOGIES MARKET SIZE, BY REVERSE TRANSCRIPTION PCR, 2018-2030 (USD MILLION)
  • TABLE 80. BRAZIL PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. BRAZIL PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. CANADA PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. CANADA PCR TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 84. CANADA PCR TECHNOLOGIES MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 85. CANADA PCR TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 86. CANADA PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 87. CANADA PCR TECHNOLOGIES MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 88. CANADA PCR TECHNOLOGIES MARKET SIZE, BY REVERSE TRANSCRIPTION PCR, 2018-2030 (USD MILLION)
  • TABLE 89. CANADA PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. CANADA PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. MEXICO PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. MEXICO PCR TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 93. MEXICO PCR TECHNOLOGIES MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 94. MEXICO PCR TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 95. MEXICO PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 96. MEXICO PCR TECHNOLOGIES MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 97. MEXICO PCR TECHNOLOGIES MARKET SIZE, BY REVERSE TRANSCRIPTION PCR, 2018-2030 (USD MILLION)
  • TABLE 98. MEXICO PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. MEXICO PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED STATES PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED STATES PCR TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED STATES PCR TECHNOLOGIES MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED STATES PCR TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED STATES PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 105. UNITED STATES PCR TECHNOLOGIES MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 106. UNITED STATES PCR TECHNOLOGIES MARKET SIZE, BY REVERSE TRANSCRIPTION PCR, 2018-2030 (USD MILLION)
  • TABLE 107. UNITED STATES PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. UNITED STATES PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. UNITED STATES PCR TECHNOLOGIES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC PCR TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC PCR TECHNOLOGIES MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC PCR TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC PCR TECHNOLOGIES MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC PCR TECHNOLOGIES MARKET SIZE, BY REVERSE TRANSCRIPTION PCR, 2018-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC PCR TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 120. AUSTRALIA PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. AUSTRALIA PCR TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 122. AUSTRALIA PCR TECHNOLOGIES MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 123. AUSTRALIA PCR TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 124. AUSTRALIA PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 125. AUSTRALIA PCR TECHNOLOGIES MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 126. AUSTRALIA PCR TECHNOLOGIES MARKET SIZE, BY REVERSE TRANSCRIPTION PCR, 2018-2030 (USD MILLION)
  • TABLE 127. AUSTRALIA PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. AUSTRALIA PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. CHINA PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. CHINA PCR TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 131. CHINA PCR TECHNOLOGIES MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 132. CHINA PCR TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 133. CHINA PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 134. CHINA PCR TECHNOLOGIES MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 135. CHINA PCR TECHNOLOGIES MARKET SIZE, BY REVERSE TRANSCRIPTION PCR, 2018-2030 (USD MILLION)
  • TABLE 136. CHINA PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. CHINA PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. INDIA PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. INDIA PCR TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 140. INDIA PCR TECHNOLOGIES MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 141. INDIA PCR TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 142. INDIA PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 143. INDIA PCR TECHNOLOGIES MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 144. INDIA PCR TECHNOLOGIES MARKET SIZE, BY REVERSE TRANSCRIPTION PCR, 2018-2030 (USD MILLION)
  • TABLE 145. INDIA PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. INDIA PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. INDONESIA PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. INDONESIA PCR TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 149. INDONESIA PCR TECHNOLOGIES MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 150. INDONESIA PCR TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 151. INDONESIA PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 152. INDONESIA PCR TECHNOLOGIES MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 153. INDONESIA PCR TECHNOLOGIES MARKET SIZE, BY REVERSE TRANSCRIPTION PCR, 2018-2030 (USD MILLION)
  • TABLE 154. INDONESIA PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. INDONESIA PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. JAPAN PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. JAPAN PCR TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 158. JAPAN PCR TECHNOLOGIES MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 159. JAPAN PCR TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 160. JAPAN PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 161. JAPAN PCR TECHNOLOGIES MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 162. JAPAN PCR TECHNOLOGIES MARKET SIZE, BY REVERSE TRANSCRIPTION PCR, 2018-2030 (USD MILLION)
  • TABLE 163. JAPAN PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. JAPAN PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. MALAYSIA PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. MALAYSIA PCR TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 167. MALAYSIA PCR TECHNOLOGIES MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 168. MALAYSIA PCR TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 169. MALAYSIA PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 170. MALAYSIA PCR TECHNOLOGIES MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 171. MALAYSIA PCR TECHNOLOGIES MARKET SIZE, BY REVERSE TRANSCRIPTION PCR, 2018-2030 (USD MILLION)
  • TABLE 172. MALAYSIA PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. MALAYSIA PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. PHILIPPINES PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. PHILIPPINES PCR TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 176. PHILIPPINES PCR TECHNOLOGIES MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 177. PHILIPPINES PCR TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 178. PHILIPPINES PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 179. PHILIPPINES PCR TECHNOLOGIES MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 180. PHILIPPINES PCR TECHNOLOGIES MARKET SIZE, BY REVERSE TRANSCRIPTION PCR, 2018-2030 (USD MILLION)
  • TABLE 181. PHILIPPINES PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. PHILIPPINES PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. SINGAPORE PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. SINGAPORE PCR TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 185. SINGAPORE PCR TECHNOLOGIES MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 186. SINGAPORE PCR TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 187. SINGAPORE PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 188. SINGAPORE PCR TECHNOLOGIES MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 189. SINGAPORE PCR TECHNOLOGIES MARKET SIZE, BY REVERSE TRANSCRIPTION PCR, 2018-2030 (USD MILLION)
  • TABLE 190. SINGAPORE PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. SINGAPORE PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. SOUTH KOREA PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. SOUTH KOREA PCR TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 194. SOUTH KOREA PCR TECHNOLOGIES MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 195. SOUTH KOREA PCR TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 196. SOUTH KOREA PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 197. SOUTH KOREA PCR TECHNOLOGIES MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH KOREA PCR TECHNOLOGIES MARKET SIZE, BY REVERSE TRANSCRIPTION PCR, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH KOREA PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH KOREA PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 201. TAIWAN PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. TAIWAN PCR TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 203. TAIWAN PCR TECHNOLOGIES MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 204. TAIWAN PCR TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 205. TAIWAN PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 206. TAIWAN PCR TECHNOLOGIES MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 207. TAIWAN PCR TECHNOLOGIES MARKET SIZE, BY REVERSE TRANSCRIPTION PCR, 2018-2030 (USD MILLION)
  • TABLE 208. TAIWAN PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. TAIWAN PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 210. THAILAND PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. THAILAND PCR TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 212. THAILAND PCR TECHNOLOGIES MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 213. THAILAND PCR TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 214. THAILAND PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 215. THAILAND PCR TECHNOLOGIES MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 216. THAILAND PCR TECHNOLOGIES MARKET SIZE, BY REVERSE TRANSCRIPTION PCR, 2018-2030 (USD MILLION)
  • TABLE 217. THAILAND PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. THAILAND PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 219. VIETNAM PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. VIETNAM PCR TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 221. VIETNAM PCR TECHNOLOGIES MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 222. VIETNAM PCR TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 223. VIETNAM PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 224. VIETNAM PCR TECHNOLOGIES MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 225. VIETNAM PCR TECHNOLOGIES MARKET SIZE, BY REVERSE TRANSCRIPTION PCR, 2018-2030 (USD MILLION)
  • TABLE 226. VIETNAM PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 227. VIETNAM PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA PCR TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA PCR TECHNOLOGIES MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA PCR TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA PCR TECHNOLOGIES MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA PCR TECHNOLOGIES MARKET SIZE, BY REVERSE TRANSCRIPTION PCR, 2018-2030 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA PCR TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 238. DENMARK PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 239. DENMARK PCR TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 240. DENMARK PCR TECHNOLOGIES MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 241. DENMARK PCR TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 242. DENMARK PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 243. DENMARK PCR TECHNOLOGIES MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 244. DENMARK PCR TECHNOLOGIES MARKET SIZE, BY REVERSE TRANSCRIPTION PCR, 2018-2030 (USD MILLION)
  • TABLE 245. DENMARK PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 246. DENMARK PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 247. EGYPT PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 248. EGYPT PCR TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 249. EGYPT PCR TECHNOLOGIES MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 250. EGYPT PCR TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 251. EGYPT PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 252. EGYPT PCR TECHNOLOGIES MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 253. EGYPT PCR TECHNOLOGIES MARKET SIZE, BY REVERSE TRANSCRIPTION PCR, 2018-2030 (USD MILLION)
  • TABLE 254. EGYPT PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 255. EGYPT PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 256. FINLAND PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 257. FINLAND PCR TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 258. FINLAND PCR TECHNOLOGIES MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 259. FINLAND PCR TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 260. FINLAND PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 261. FINLAND PCR TECHNOLOGIES MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 262. FINLAND PCR TECHNOLOGIES MARKET SIZE, BY REVERSE TRANSCRIPTION PCR, 2018-2030 (USD MILLION)
  • TABLE 263. FINLAND PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 264. FINLAND PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 265. FRANCE PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 266. FRANCE PCR TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 267. FRANCE PCR TECHNOLOGIES MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 268. FRANCE PCR TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 269. FRANCE PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 270. FRANCE PCR TECHNOLOGIES MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 271. FRANCE PCR TECHNOLOGIES MARKET SIZE, BY REVERSE TRANSCRIPTION PCR, 2018-2030 (USD MILLION)
  • TABLE 272. FRANCE PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 273. FRANCE PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 274. GERMANY PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 275. GERMANY PCR TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 276. GERMANY PCR TECHNOLOGIES MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 277. GERMANY PCR TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 278. GERMANY PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 279. GERMANY PCR TECHNOLOGIES MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 280. GERMANY PCR TECHNOLOGIES MARKET SIZE, BY REVERSE TRANSCRIPTION PCR, 2018-2030 (USD MILLION)
  • TABLE 281. GERMANY PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 282. GERMANY PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 283. ISRAEL PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 284. ISRAEL PCR TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 285. ISRAEL PCR TECHNOLOGIES MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 286. ISRAEL PCR TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 287. ISRAEL PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 288. ISRAEL PCR TECHNOLOGIES MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 289. ISRAEL PCR TECHNOLOGIES MARKET SIZE, BY REVERSE TRANSCRIPTION PCR, 2018-2030 (USD MILLION)
  • TABLE 290. ISRAEL PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 291. ISRAEL PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 292. ITALY PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 293. ITALY PCR TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 294. ITALY PCR TECHNOLOGIES MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 295. ITALY PCR TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 296. ITALY PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 297. ITALY PCR TECHNOLOGIES MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 298. ITALY PCR TECHNOLOGIES MARKET SIZE, BY REVERSE TRANSCRIPTION PCR, 2018-2030 (USD MILLION)
  • TABLE 299. ITALY PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 300. ITALY PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 301. NETHERLANDS PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 302. NETHERLANDS PCR TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 303. NETHERLANDS PCR TECHNOLOGIES MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 304. NETHERLANDS PCR TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 305. NETHERLANDS PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 306. NETHERLANDS PCR TECHNOLOGIES MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 307. NETHERLANDS PCR TECHNOLOGIES MARKET SIZE, BY REVERSE TRANSCRIPTION PCR, 2018-2030 (USD MILLION)
  • TABLE 308. NETHERLANDS PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 309. NETHERLANDS PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 310. NIGERIA PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 311. NIGERIA PCR TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 312. NIGERIA PCR TECHNOLOGIES MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 313. NIGERIA PCR TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 314. NIGERIA PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 315. NIGERIA PCR TECHNOLOGIES MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 316. NIGERIA PCR TECHNOLOGIES MARKET SIZE, BY REVERSE TRANSCRIPTION PCR, 2018-2030 (USD MILLION)
  • TABLE 317. NIGERIA PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 318. NIGERIA PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 319. NORWAY PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 320. NORWAY PCR TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 321. NORWAY PCR TECHNOLOGIES MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 322. NORWAY PCR TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 323. NORWAY PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 324. NORWAY PCR TECHNOLOGIES MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 325. NORWAY PCR TECHNOLOGIES MARKET SIZE, BY REVERSE TRANSCRIPTION PCR, 2018-2030 (USD MILLION)
  • TABLE 326. NORWAY PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 327. NORWAY PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 328. POLAND PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 329. POLAND PCR TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 330. POLAND PCR TECHNOLOGIES MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 331. POLAND PCR TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 332. POLAND PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 333. POLAND PCR TECHNOLOGIES MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 334. POLAND PCR TECHNOLOGIES MARKET SIZE, BY REVERSE TRANSCRIPTION PCR, 2018-2030 (USD MILLION)
  • TABLE 335. POLAND PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 336. POLAND PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 337. QATAR PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 338. QATAR PCR TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 339. QATAR PCR TECHNOLOGIES MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 340. QATAR PCR TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 341. QATAR PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 342. QATAR PCR TECHNOLOGIES MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 343. QATAR PCR TECHNOLOGIES MARKET SIZE, BY REVERSE TRANSCRIPTION PCR, 2018-2030 (USD MILLION)
  • TABLE 344. QATAR PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 345. QATAR PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 346. RUSSIA PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 347. RUSSIA PCR TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 348. RUSSIA PCR TECHNOLOGIES MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 349. RUSSIA PCR TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, 2018-20